NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/08/2023
Back to search
Official data from USPTO
AB CHECK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
55
Latest update
08/08/2023
Trademark type
Combined
Nice classes
42
Filing date
08/10/2018
Registration date
08/08/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/08/2023
Last transaction
08/08/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/27/2021
First use in commerce
09/27/2021
Drawing code
3
Owner type
16
Owner location
Plzen, CZ
Examiner
AVENT, TEAGUE
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of letters "AB" and "CHECK" separated by an array of circles.
Holders and representatives
Holders
A. S. (pessoa física)
Representatives
Karen L. Elbing CLARK+ELBING LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific and technological services and research projects for the preparation of peptide and antibody librarieschemical analysis; scientific and technological services and research projects for the identification and characterisation of binding moleculesin the field of antibody discoveryantibody research and antibody optimization in the nature of working on and evaluation of chemical analyses; scientific and technological services and research projects for the preparationidentification and characterisation of peptides and antibodiesmedical research in the field of antibody discoveryantibody research and antibody optimization; scientific and technological services and research projects for the preparation and identification of recombinant antibodiessingle-chain antibodiesdiabodiestandabsflexibodiestriabodiestetrabodiesbivalent antibodiesmultivalent antibodieswhole immunoglobulinsantibody fragmentsin particular Fab and scFv fragmentsof nucleic acid sequences coding for these moleculesin the field of antibody discoveryantibody research and antibody optimizationscientific research in the field of antibodies; scientific and technological services and research projects in relation to antibody discoverymedical research in the field of antibody research and drug design; scientific and technological services and research projects in relation to screening of naturalengineered and immunized librariesmedical research in the field of antibody discovery for scientific research services; scientific and technological services and research projects in relation to screening of antibody librariesin the field of antibody discovery for scientific research services; scientific and technological services and research projects in relation to phage displayphage panning and yeast display vectorsin the field of antibody discovery in the nature of chemical analysis; scientific and technological services and research projects in relation to next-generation yeast display and antibody selection processin the field of antibody discovery in the nature of chemical analysis; scientific and technological services and research projects in relation to the upstream enrichment of target-specific candidates and batch cloning into yeast-display vectors in the nature of research and development services in the field of antibodies; scientific and technological services in relation to drug discovery by high throughput screen and antibody delivery for therapeutic applicationscientific research in the field of antibody research and drug design; scientific and technological services and research projects in relation to batch-cloning and screening of naturalengineered and immunized librariesscientific research in the field of antibodies and antibody optimization; scientific and technological services and research projects in relation to batch-cloning and screening of antibody librariesscientific research in the field of antibodies and antibody optimization; scientific and technological services and research projects in relation to antibody development strategiesscientific research in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to the optimizationmaturation and humanization of antibody drug candidatesin the field of antibody research and drug design; scientific and technological services and research projects in relation to multi-factor antibody optimizationscientific research in the field of antibody research and drug design; scientific and technological services and research projects in relation to the optimization of antibody binding affinityantibody stabilityspecies cross-reactivityspecificitydevelopabilityproducibilityhuman propertiesscientific research in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to human and non-human lead antibody technologyscientific research in the field of antibody research and antibody optimization
Publications
History of USPTO decisions and trademark events.
55 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/08/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/06/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/05/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/09/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/08/2023
EX5G
SOU EXTENSION 5 GRANTED
06/08/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/30/2023
EXT5
SOU EXTENSION 5 FILED
05/24/2023
IUAF
USE AMENDMENT FILED
05/24/2023
EEXT
SOU TEAS EXTENSION RECEIVED
05/24/2023
EISU
TEAS STATEMENT OF USE RECEIVED
05/24/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/01/2022
EX4G
SOU EXTENSION 4 GRANTED
10/28/2022
EXT4
SOU EXTENSION 4 FILED
10/28/2022
EEXT
SOU TEAS EXTENSION RECEIVED
10/28/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/19/2022
EX3G
SOU EXTENSION 3 GRANTED
05/17/2022
EXT3
SOU EXTENSION 3 FILED
05/17/2022
EEXT
SOU TEAS EXTENSION RECEIVED
05/17/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/28/2021
EX2G
SOU EXTENSION 2 GRANTED
10/26/2021
EXT2
SOU EXTENSION 2 FILED
10/26/2021
EEXT
SOU TEAS EXTENSION RECEIVED
10/26/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/22/2021
EX1G
SOU EXTENSION 1 GRANTED
04/20/2021
EXT1
SOU EXTENSION 1 FILED
04/20/2021
EEXT
SOU TEAS EXTENSION RECEIVED
04/20/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/24/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/29/2020
PUBO
PUBLISHED FOR OPPOSITION
09/29/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/09/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/26/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/25/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/25/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/25/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/19/2020
GNFR
FINAL REFUSAL E-MAILED
04/19/2020
CNFR
FINAL REFUSAL WRITTEN
04/19/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/16/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/15/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/15/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/17/2019
GNRT
NON-FINAL ACTION E-MAILED
07/17/2019
CNRT
NON-FINAL ACTION WRITTEN
07/17/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/13/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/13/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/13/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/02/2019
GNRT
NON-FINAL ACTION E-MAILED
01/02/2019
CNRT
NON-FINAL ACTION WRITTEN
01/02/2019
DOCK
ASSIGNED TO EXAMINER
11/28/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/21/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/18/2018
NWAP
NEW APPLICATION ENTERED
08/14/2018
Continuous trademark protection
Get notified about every new filing that threatens AB CHECK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.